Delivery Order SPE2DR25D2206-SPE2DR26F9JF5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Phenobarbital 130 mg/ml in vial form, with a contract ceiling value of $2,611.73 and an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,095.09 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials, with an ultimate completion date of July 21, 2025. This non-set-aside contract employs firm fixed pricing and represents a discrete purchase order under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Phenobarbital 130 mg/mL in vial form, with a firm fixed price ceiling value of $4,088.90 and an ultimate completion date of December 23, 2025. This is a non-set-aside competitive award issued as a child delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/mL vials valued at $3,749.73 on September 29, 2025. This firm fixed-price, competitively awarded delivery order is non-set-aside and scheduled for completion by September 30, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a continuation of the company's substantial pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,019.16 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This non-set-aside, competitively awarded contract employs firm fixed pricing and was executed on April 24, 2025, with an ultimate completion date of April 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,839.58 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of December 22, 2025, and represents a single delivery order under AmerisourceBergen's larger federal contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,789.75 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This firm fixed-price, competitively awarded contract contains no set-aside designation and is scheduled for completion by July 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $13,857.65 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 130 mg/mL vials of the pharmaceutical Phenobarbital. This delivery order was issued under an Indefinite Delivery Contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency awarded a $6,483.54 delivery order to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/ml vial on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This...
- The Defense Logistics Agency awarded a $7,103.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/ml in vial format. The contract was competitively awarded without set-aside designation and is scheduled for completion by October 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9JF5Delivery Order
The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials with a ceiling value of $2,522.26. This firm fixed-price delivery order was competitively awarded without set-aside designations and is scheduled for completion by January 5, 2026. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, serving federal medical procurement needs across the military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and other critical medical commodities. The Defense Logistics Agency's Medical Supply Chain utilizes such vehicles to ensure reliable pharmaceutical distribution to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 1/1/26 |